Is MTHFR A1298C AC a stand-alone explanation for elevated homocysteine?

MTHFR testing is frequently overinterpreted in evaluations of homocysteine, vascular risk, or nonspecific “methylation” concerns. The evidence supports a meaningful distinction between C677T and A1298C, particularly for an isolated A1298C AC genotype.

Clinical and biochemical evidence

• C677T is the stronger comparator: a systematic review/meta-analysis of 256 studies (114,799 participants) found consistently higher total homocysteine, particularly in TT homozygotes. Folate status substantially modifies this association.
• A1298C is weaker and conditional: a 2018 systematic review/meta-analysis found no significant homocysteine difference for AC versus AA (+0.55 µmol/L; 95% CI −0.72 to 1.82), and another meta-analysis found no significant blood-folate difference. Some compound-genotype cohorts report higher homocysteine, but this does not establish a reliable independent effect of A1298C alone.
• Therefore, AC is not a sufficient explanation for symptoms, elevated homocysteine, or broad claims of impaired methylation.

Mechanistic and clinical context

• Functional data suggest AC retains approximately 83% of typical MTHFR activity, consistent with a modest biochemical effect rather than severe enzyme impairment.
• Any effect is contingent on folate and vitamin B12 availability, co-inherited variants such as C677T, medications and nutritional exposures, and renal function. Renal impairment independently raises homocysteine, making kidney assessment particularly relevant in an older adult.
• Direct evidence that AC produces a reproducible, clinically defined alteration in DNA methylation or “methylation capacity” is lacking.

Practical interpretation

• When clinically indicated, measure plasma total homocysteine rather than infer it from genotype. If elevated, prioritize folate, B12, renal, and thyroid assessment and other secondary causes; marked elevations are not adequately explained by common MTHFR variants.
• Bottom line: The claim is well supported overall: A1298C AC is best regarded as a context-dependent, modest vulnerability—not a stand-alone diagnosis or explanation—whereas C677T has the more consistent association with elevated homocysteine.